“…Those studies that do suggest a relationship demonstrate reductions in allopregnanolone levels in women with a risk of developing postpartum depression (Osborne et al, 2017), a reduction in women experiencing postpartum blues (Nappi et al, 2001b), and a negative correlation with depression symptoms in postpartum women (Hellgren et al, 2014); whereas, others have failed to find a relationship between allopregnanolone levels and postpartum depression (Deligiannidis et al, 2013a, 2013b, 2016; Epperson et al, 2006a, 2006b). In fact, one study measured elevated levels of allopregnanolone in women with postpartum depression (Deligiannidis et al, 2019), although this increase is proposed to be a compensatory mechanism (personal communication with Dr. Kristina Deligiannidis), and positively correlates with observed differences in the connectivity of the dorsomedial prefrontal cortex within the default mode network which are correlated with depression scores (Deligiannidis et al, 2019). In fact, alterations in neurosteroid levels, particularly allopregnanolone, have been proposed to mediate affective switching in relation to reproductive mood disorders (Schiller et al, 2014).…”